Meaghan Elizabeth Curley, AUD | |
38 6th Ave, Brooklyn, NY 11217-4187 | |
(718) 362-3260 | |
Not Available |
Full Name | Meaghan Elizabeth Curley |
---|---|
Gender | Female |
Speciality | Qualified Audiologist |
Experience | 4 Years |
Location | 38 6th Ave, Brooklyn, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316539034 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 1122940567 (New York) | Secondary |
231H00000X | Audiologist | 002944 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kings Physician Services Pc | 0547579427 | 481 |
News Archive
The University of Oxford and SomaLogic announced today that they have agreed to undertake a number of collaborative projects that will employ SomaLogic's proprietary SOMAmer reagents and SOMAscan assay technologies to discover and characterize protein biomarkers for a range of clinical diseases and conditions.
Caris Life Sciences announced today data from two studies presented at the 2013 European Cancer Congress, which demonstrate the potential of evidence-guided molecular profiling to immediately improve the treatment of patients with hard-to-treat cancers, including cancers of unknown primary (CUP) origins as well as rare tumors and cancers that have been refractory to treatment.
The outcome of the current healthcare legislation is uncertain, but one matter is clear: Americans need to get healthier. From childhood obesity to alarming rates of clinical depression among adults, people across the U.S. have been confronted with the consequences of lives off-balance.
The Pan American Health Organization (PAHO) launched a new regional plan of action to eliminate congenital syphilis from the Americas during the Global Health Council conference "Youth and Health: Generation on the Edge," held June 1 to 4 in Washington, D.C.
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual Meeting in San Francisco.
› Verified 8 days ago
Entity Name | Kings Physician Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083045090 PECOS PAC ID: 0547579427 Enrollment ID: O20151015000175 |
News Archive
The University of Oxford and SomaLogic announced today that they have agreed to undertake a number of collaborative projects that will employ SomaLogic's proprietary SOMAmer reagents and SOMAscan assay technologies to discover and characterize protein biomarkers for a range of clinical diseases and conditions.
Caris Life Sciences announced today data from two studies presented at the 2013 European Cancer Congress, which demonstrate the potential of evidence-guided molecular profiling to immediately improve the treatment of patients with hard-to-treat cancers, including cancers of unknown primary (CUP) origins as well as rare tumors and cancers that have been refractory to treatment.
The outcome of the current healthcare legislation is uncertain, but one matter is clear: Americans need to get healthier. From childhood obesity to alarming rates of clinical depression among adults, people across the U.S. have been confronted with the consequences of lives off-balance.
The Pan American Health Organization (PAHO) launched a new regional plan of action to eliminate congenital syphilis from the Americas during the Global Health Council conference "Youth and Health: Generation on the Edge," held June 1 to 4 in Washington, D.C.
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual Meeting in San Francisco.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Meaghan Elizabeth Curley, AUD 38 6th Ave, Brooklyn, NY 11217-4187 Ph: (183) 623-2607 | Meaghan Elizabeth Curley, AUD 38 6th Ave, Brooklyn, NY 11217-4187 Ph: (718) 362-3260 |
News Archive
The University of Oxford and SomaLogic announced today that they have agreed to undertake a number of collaborative projects that will employ SomaLogic's proprietary SOMAmer reagents and SOMAscan assay technologies to discover and characterize protein biomarkers for a range of clinical diseases and conditions.
Caris Life Sciences announced today data from two studies presented at the 2013 European Cancer Congress, which demonstrate the potential of evidence-guided molecular profiling to immediately improve the treatment of patients with hard-to-treat cancers, including cancers of unknown primary (CUP) origins as well as rare tumors and cancers that have been refractory to treatment.
The outcome of the current healthcare legislation is uncertain, but one matter is clear: Americans need to get healthier. From childhood obesity to alarming rates of clinical depression among adults, people across the U.S. have been confronted with the consequences of lives off-balance.
The Pan American Health Organization (PAHO) launched a new regional plan of action to eliminate congenital syphilis from the Americas during the Global Health Council conference "Youth and Health: Generation on the Edge," held June 1 to 4 in Washington, D.C.
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual Meeting in San Francisco.
› Verified 8 days ago